| __timestamp | Teva Pharmaceutical Industries Limited | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 5078000000 | 2999000 |
| Thursday, January 1, 2015 | 4717000000 | 10393000 |
| Friday, January 1, 2016 | 5096000000 | 15994000 |
| Sunday, January 1, 2017 | 4986000000 | 26975000 |
| Monday, January 1, 2018 | 4214000000 | 39509000 |
| Tuesday, January 1, 2019 | 3806000000 | 48869000 |
| Wednesday, January 1, 2020 | 3671000000 | 42510000 |
| Friday, January 1, 2021 | 3528000000 | 46105000 |
| Saturday, January 1, 2022 | 3445000000 | 50513000 |
| Sunday, January 1, 2023 | 3498000000 | 51292000 |
| Monday, January 1, 2024 | 3702000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, understanding spending patterns is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and Wave Life Sciences Ltd. have showcased contrasting approaches to their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Teva's SG&A expenses have seen a significant decline of approximately 31%, dropping from $5.08 billion to $3.50 billion. This reduction reflects Teva's strategic cost-cutting measures amidst industry challenges.
Conversely, Wave Life Sciences has experienced a remarkable increase in SG&A spending, surging by over 1,600% from a modest $3 million in 2014 to $51 million in 2023. This growth underscores Wave's aggressive expansion and investment in its operational capabilities. These divergent trends highlight the distinct strategic priorities of these companies, offering valuable insights into their market positioning and future trajectories.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited and United Therapeutics Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? MorphoSys AG or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Catalyst Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Geron Corporation or Wave Life Sciences Ltd.
Wave Life Sciences Ltd. and Novavax, Inc.: SG&A Spending Patterns Compared